Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02754726

Recruitment Status : Active, not recruiting

First Posted : April 28, 2016

Last Update Posted : March 3, 2022

Sponsor:

Collaborators:

Translational Genomics Research Institute

Bristol-Myers Squibb

Lustgarten Foundation

Information provided by (Responsible Party):

HonorHealth Research Institute

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	December 31, 2022
Estimated Study Completion Date :	June 2023

To Top